New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > PRO PHARMACEUTICALS INC
PRO PHARMACEUTICALS INC
Industry: Life Sciences ・ $GALT on Nasdaq ・ Market Cap: Micro
CEO Purchases
High Purchases Frequency
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
| TRADES PURCHASE/SALE Sector Average | 12 / 1 2.19 / 7.65 |
| INSIDER BUYERS/SELLERS Sector Average | 4 / 1 1.2 / 2.5 |
| SHARES PURCHASED/SOLD Transaction Average | 23,100 / 25,000 1,925 / 25,000 |
| VALUE PURCHASED/SOLD Transaction Average | $61,599 / $76,500 $5,133 / $76,500 |
| PURCHASE RANGE | $895 - $13,500 |
| SALE RANGE | $76,500 - $76,500 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
2 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
0 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
100%
DIRECTORS
0%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.533 0.2 |
VALUE GINI INDEX Sector Average | 0.531 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
0%
DIRECTORS
0%
OFFICERS
100%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | N/A 0.295 |
VALUE GINI INDEX Sector Average | N/A 0.288 |
PRO PHARMACEUTICALS INC 1Y Trade Transactions
Submission Date Period of Report | Insider | Position | Total Value | Shares | Share Price | Ownership % Change | Shares Owned | Post Day Stock Change | Post Week Stock Change | |
|---|---|---|---|---|---|---|---|---|---|---|
2024-10-17 2024-10-17 | FREEMAN KEVIN D | Director | +$3,432 | 1,300 | $2.64 | +0.99% | 132,832 | N/A | N/A | |
2024-10-16 2024-10-16 | FREEMAN KEVIN D | Director | +$13,500 | 5,000 | $2.7 | +3.95% | 131,532 | +1.14% | N/A | |
2024-10-16 2024-10-16 | FREEMAN KEVIN D | Director | +$13,500 | 5,000 | $2.7 | +3.95% | 131,532 | +1.14% | N/A | |
2024-08-26 2024-08-22 | Zordani Richard A. Jr. | Director | +$2,300 | 1,000 | $2.3 | +3.02% | 34,083 | +7.82% | +2.88% | |
2024-08-26 2024-08-22 | Zordani Richard A. Jr. | Director | +$5,750 | 2,500 | $2.3 | +7.92% | 34,083 | +7.82% | +2.88% | |
2024-07-23 2024-07-22 | ELDRED KARY | Director | +$956 | 400 | $2.39 | +0.74% | 54,138 | -0.39% | -5.21% | |
2024-07-23 2024-07-22 | ELDRED KARY | Director | +$956 | 400 | $2.39 | +0.74% | 54,138 | -0.39% | -5.21% | |
2024-06-20 2024-06-20 | FREEMAN KEVIN D | Director | +$5,950 | 2,500 | $2.38 | +2.1% | 121,532 | -3.31% | -9.09% | |
2024-04-30 2024-04-30 | Zordani Richard A. Jr. | Director | +$3,520 | 1,000 | $3.52 | +3.38% | 30,583 | -0.28% | -4.56% | |
2024-04-25 2024-04-24 | LEWIS JOEL | Director | +$3,390 | 1,000 | $3.39 | +0.11% | 899,012 | -1.43% | -3.71% |